Genomics and Genetics

Researchers: Therapeutic cloning ban could hurt economy

Published in Food and Drug Law Weekly, March 11th, 2005

Since opening its doors in 2000, Kansas City's Stowers Institute for Medical Research has recruited scientists from across the country to do stem cell research in the hope that cures can be found for diseases such as diabetes and dementia.

But that research may be in jeopardy.

A Senate committee voted 7-2 February 14, 2005, night to endorse legislation intending to ban "therapeutic cloning", a procedure used to create stem cells. The bill now goes to the Senate.

If the ban becomes law, the institute would look elsewhere to build its planned 600,000-square-foot expansion, which would cost Missouri hundreds of new jobs, said William...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly

Source: Food and Drug Law Weekly (2005-03-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry